EUVIMEDEUVIMED entdecken
Crossref

Dual Targeting Biomimetic Nanoplatform Eradicates Oncogenic Bacteria While Reinvigorating Anti-Tumor Immunity in Breast Cancer

Lan Yang, Yongshun Zhang, Tianyuan Chen, Jiaxi Han, Hairui Wang, Mengxing Zhang, Qixue Bao, Zhenkang Diao iD, Taotian Zhang, Yilin Jiang, Shiqi Huang, Ling Zhang iD

ACS Applied Materials & Interfaces · 2025

DOI: 10.1021/acsami.5c16642 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2025. Verfasst von Lan Yang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Med-X Center for Materials, College of Polymer Science and Engineering, Sichuan University, Chengdu 610065, People's Republic of China. Hauptthemen laut MEDLINE: Biomimetic Materials, Nanoparticles, Triple Negative Breast Neoplasms, Fusobacterium nucleatum. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Regional Innovation and Development Joint Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mounting evidence reveals that intratumoral microbiota, particularly Fusobacterium nucleatum (Fn), promote immunosuppression in the tumor microenvironment. We discovered that celastrol (CLT) displays concurrent cytotoxicity against triple-negative breast cancer (TNBC) cells and bactericidal effects against Fn. To exploit this unique dual-functionality, we developed a biomimetic system (CiTB) using hybrid membranes from engineered T cells and Fn to wrap CLT-loaded PLGA nanoparticles. This design utilizes overexpressed PD-1 on the T cell membrane and Fap2 proteins on the Fn membrane to target PD-L1 and Gal-GalNAc residues overexpressed on tumor cell surfaces, respectively. Importantly, this biomimetic system reprograms the tumor microenvironment through four synergistic effects: (1) directly clearing Fn to break bacteria-induced immunosuppression, (2) immune reactivation via PD-1 membrane mediated immune checkpoint blockade, (3) enhanced synergistic immunity characterized by NK cells and T cell infiltration, and (4) in-situ vaccination through combined bacterial component adjuvanticity and tumor antigen release. In Fn-colonized TNBC models, CiTB exhibited superior tumor accumulation and suppression as well as significant median survival length extension (from 23 to 44.5 days). CiTB also exhibited excellent biosafety without gut microbiome disruption. Thus, this study provides both a new nonantibiotic option for treating intratumor bacteria and a new biomimetic hybrid membrane technique for tumor targeting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomimetic MaterialsNanoparticlesTriple Negative Breast NeoplasmsFusobacterium nucleatumAntineoplastic AgentsAnti-Bacterial AgentsFemaleHumansMiceAnimalsTumor MicroenvironmentCell Line, TumorProgrammed Cell Death 1 ReceptorB7-H1 Antigen

Stichwörter der Autor:innen

CelastrolFusobacterium nucleatumPD-1/Fap2 dual-targetedcombined antibacterial and antitumor therapyhybrid membrane nanoparticlesintratumoral bacterial colonization

Substanzen

Antineoplastic AgentsAnti-Bacterial AgentsProgrammed Cell Death 1 ReceptorB7-H1 Antigen

Autor:innen und Institutionen

  • Med-X Center for Materials, College of Polymer Science and Engineering, Sichuan University, Chengdu 610065, People's Republic of China.
  • Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry, West China School of Pharmacy, Sichuan University, Chengdu 610041, People's Republic of China.
  • Institute of Systems Epidemiology, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu 610041, People's Republic of China.
  • Institute of Respiratory Health, West China Hospital, Sichuan University, Chengdu 610041, People's Republic of China.

ORCID-Profile: Zhenkang Diao, Ling Zhang

Förderung

  • National Key Research and Development Program of China
  • Regional Innovation and Development Joint Fund

Zitieren

APA

Yang, L., Zhang, Y., Chen, T., Han, J., Wang, H., Zhang, M., Bao, Q., Diao, Z., Zhang, T., Jiang, Y., Huang, S., & Zhang, L. (2025). Dual Targeting Biomimetic Nanoplatform Eradicates Oncogenic Bacteria While Reinvigorating Anti-Tumor Immunity in Breast Cancer. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.5c16642

Vancouver

Yang L, Zhang Y, Chen T, Han J, Wang H, Zhang M, et al. Dual Targeting Biomimetic Nanoplatform Eradicates Oncogenic Bacteria While Reinvigorating Anti-Tumor Immunity in Breast Cancer. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.5c16642

BibTeX
@article{Yang2025,
  author = {Yang, Lan and Zhang, Yongshun and Chen, Tianyuan and Han, Jiaxi and Wang, Hairui and Zhang, Mengxing and Bao, Qixue and Diao, Zhenkang and Zhang, Taotian and Jiang, Yilin and Huang, Shiqi and Zhang, Ling},
  title = {Dual Targeting Biomimetic Nanoplatform Eradicates Oncogenic Bacteria While Reinvigorating Anti-Tumor Immunity in Breast Cancer},
  journal = {ACS Applied Materials & Interfaces},
  year = {2025},
  doi = {10.1021/acsami.5c16642}
}
Kostenlos starten →